MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy.
Saved in:
| Title: | MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy. |
|---|---|
| Authors: | Wang Y; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China., Zhao W; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China.; The First Clinical Medical School of Lanzhou University, Lanzhou, 730000, Gansu, China., Jin Y; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China., Hu C; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China.; The First Clinical Medical School of Lanzhou University, Lanzhou, 730000, Gansu, China., Fang X; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China., Dong S; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China. dongshh@lzu.edu.cn., Zhang B; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China. zhangbl@lzu.edu.cn. |
| Source: | Functional & integrative genomics [Funct Integr Genomics] 2026 Jun 17; Vol. 26 (1). Date of Electronic Publication: 2026 Jun 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 100939343 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-7948 (Electronic) Linking ISSN: 1438793X NLM ISO Abbreviation: Funct Integr Genomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
